Literature DB >> 20400218

The role of the renin-angiotensin system in the regulation of erythropoiesis.

Demetrios V Vlahakos1, Katerina P Marathias, Nicolaos E Madias.   

Abstract

The renin-angiotensin system is the major regulator of blood pressure by virtue of controlling vascular resistance and plasma volume. Much less recognition exists for the role of the renin-angiotensin system in regulating erythropoiesis, a biological function critical for oxygen delivery to tissues. In this review, we present evidence that angiotensin II (Ang II) is a physiologically important regulator of erythropoiesis with 2 key actions. First, Ang II is a growth factor of erythroid progenitors and, in cooperation with erythropoietin, increases red blood cell mass. Second, Ang II acts as an erythropoietin secretagogue to maintain increased erythropoietin levels despite increments in hematocrit. Among a multitude of physiologic and pathophysiologic implications, these lines of evidence provide an explanation for the effect of angiotensin-converting enzyme inhibitors and Ang II type 1 receptor blockers to decrease hematocrit or cause anemia in various clinical conditions. Copyright (c) 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20400218     DOI: 10.1053/j.ajkd.2009.12.042

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  35 in total

Review 1.  Regulation of erythropoietin production.

Authors:  Wolfgang Jelkmann
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

Review 2.  Anemia in critical illness: insights into etiology, consequences, and management.

Authors:  Shailaja J Hayden; Tyler J Albert; Timothy R Watkins; Erik R Swenson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

Review 3.  Physiology of the Renal Interstitium.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-26       Impact factor: 8.237

4.  Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.

Authors:  James F Crismale; Valérie Martel-Laferrière; Kian Bichoupan; Emily Schonfeld; Alexis Pappas; Christina Wyatt; Joseph A Odin; Lawrence U Liu; Thomas D Schiano; Ponni V Perumalswami; Meena Bansal; Douglas T Dieterich; Andrea D Branch
Journal:  Liver Int       Date:  2013-10-25       Impact factor: 5.828

5.  Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.

Authors:  Reham Hammad; Mona Abd El Rahman Eldosoky; Shaimaa Hani Fouad; Abdelaleem Elgendy; Amany M Tawfeik; Mohamed Alboraie; Mariam Fathy Abdelmaksoud
Journal:  Innate Immun       Date:  2021-03-01       Impact factor: 2.680

Review 6.  The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis.

Authors:  Xiao Z Shen; Kenneth E Bernstein
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

Review 7.  Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy.

Authors:  M Pappa; E Dounousi; A Duni; K Katopodis
Journal:  Int Urol Nephrol       Date:  2015-05-28       Impact factor: 2.370

Review 8.  Nontraditional roles of angiotensin-converting enzyme.

Authors:  Xiao Z Shen; Frank S Ong; Ellen A Bernstein; Tea Janjulia; Wendell-Lamar B Blackwell; Kandarp H Shah; Brian L Taylor; Romer A Gonzalez-Villalobos; Sebastien Fuchs; Kenneth E Bernstein
Journal:  Hypertension       Date:  2012-02-21       Impact factor: 10.190

9.  Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.

Authors:  Charalampos Loutradis; Alexandra Skodra; Panagiotis Georgianos; Panagiota Tolika; Dimitris Alexandrou; Afroditi Avdelidou; Pantelis A Sarafidis
Journal:  World J Nephrol       Date:  2016-07-06

10.  The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Authors:  Imran Memon; Keith C Norris; Andrew S Bomback; Carmen Peralta; Suying Li; Shu-Cheng Chen; Peter A McCullough; Adam Whaley-Connell; Claudine Jurkovitz; Manjula Kurella Tamura; Georges Saab
Journal:  Cardiorenal Med       Date:  2013-06-01       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.